BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7521976)

  • 21. HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902.
    Adams EJ; Martinez-Naves E; Arnett KL; Little AM; Tyan DB; Parham P
    Tissue Antigens; 1995 Jan; 45(1):18-26. PubMed ID: 7725307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
    J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B*1559: a hybrid allele including exon 2 of HLA-B35 and exon 3 of HLA-B15 and serologically typed as B35.
    Magira E; Beznik-Cizman B; Monos D
    Tissue Antigens; 2000 Nov; 56(5):460-2. PubMed ID: 11144297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
    Zemmour J; Parham P
    J Exp Med; 1992 Oct; 176(4):937-50. PubMed ID: 1383381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the novel allele HLA-B*1546 which belongs to the serological B72 type: implications for bone marrow transplantation.
    Elsner HA; Wölpl A; Goldmann SF; Blasczyk R
    Tissue Antigens; 2000 Jan; 55(1):83-5. PubMed ID: 10703618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules.
    Choo SY; Fan LA; Hansen JA
    Immunogenetics; 1993; 37(2):108-13. PubMed ID: 8423049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
    Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
    Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five HLA-B22 group alleles in Japanese.
    Bannai M; Tokunaga K; Tanaka H; Lin L; Kashiwase K; Tokunaga K; Juji T
    Tissue Antigens; 1997 Apr; 49(4):376-82. PubMed ID: 9151389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA class I genotyping by cDNA sequence of a Vietnamese family expressing a weak B46 antigen.
    Tzeng CM; Percival L; Barber LD; Cooper S; Adams EJ; Stewart D; Parham P
    Tissue Antigens; 1997 May; 49(5):519-22. PubMed ID: 9174148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HLA-Bw75 subtype of B15: molecular characterization and comparison with crossreacting antigens.
    Little AM; Parham P
    Tissue Antigens; 1991 Oct; 38(4):186-90. PubMed ID: 1801311
    [No Abstract]   [Full Text] [Related]  

  • 31. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.
    Parham P; Arnett KL; Adams EJ; Barber LD; Domena JD; Stewart D; Hildebrand WH; Little AM
    Tissue Antigens; 1994 May; 43(5):302-13. PubMed ID: 7524186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.
    Madrigal JA; Belich MP; Benjamin RJ; Little AM; Hildebrand WH; Mann DL; Parham P
    J Exp Med; 1991 Nov; 174(5):1085-95. PubMed ID: 1940790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new HLA-B44 variant (B44BO [B*4408]) identified by serology.
    Darke C; Street J; Fussell H; Thomas M; Guttridge M; Goldberg TE; Arnett KL; Parham P
    Tissue Antigens; 1997 Jul; 50(1):32-7. PubMed ID: 9243752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-B*1303: a new example of poor correlation between serology and structure.
    Balas A; García-Sánchez F; Vicario JL
    Hum Immunol; 1996 Jan; 45(1):32-6. PubMed ID: 8655357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.
    Zemmour J; Gumperz JE; Hildebrand WH; Ward FE; Marsh SG; Williams RC; Parham P
    Tissue Antigens; 1992 May; 39(5):249-57. PubMed ID: 1384166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.
    Ellexson ME; Zhang G; Stewart D; Lau M; Teresi G; Terasaki P; Roe B; Hildebrand W
    Hum Immunol; 1995 Oct; 44(2):103-10. PubMed ID: 8847228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel HLA-B*40 sequence--B*40:92.
    Street J; Johnson J; Hammond L; Pepperall J; Darke C
    Int J Immunogenet; 2011 Apr; 38(2):161-6. PubMed ID: 21208379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing.
    Petersdorf EW; Hansen JA
    Tissue Antigens; 1995 Aug; 46(2):73-85. PubMed ID: 7482511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel HLA-B alleles, B*8201, B*3515 and B*5106, add to the complexity of serologic identification of HLA types.
    Hurley CK; Steiner N; Hoyer RJ; Menchaca E; Mitton W; Simonis T; Hartzman RJ; Johnson AH; Ng J
    Tissue Antigens; 1996 Mar; 47(3):179-87. PubMed ID: 8740766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.